PulseOn closes €1M seed investment round to launch innovation in optical heart rate monitoring

NewsGuard 100/100 Score

Finnish mobile wellness technology company PulseOn has closed a €1m seed investment round to finalize and launch its ground-breaking innovation in optical heart rate monitoring.  The company targets the booming market for wearable and biometrical consumer sensors with its comprehensive multipurpose heart rate monitoring solution which is the world's easiest to use and accurate wrist device for sports and 24/7 use. The wrist device is based on PulseOn's disruptive and proprietary optical heart measurement technology. It can measure heart rate with beat-to-beat accuracy which enables multiple use cases for exercising, activity, recovery, stress, and sleep monitoring. The device is seamlessly integrated with mobile apps which offer meaningful and motivating feedback based on heart rate analytics.

PulseOn currently has 13 employees and is based in Finland. The company is a spin-off from Nokia and was founded in November 2012. The team consists of researchers and experts in sensor technology, algorithms and mobile technology, in addition to strong productization and commercialization experience.

"With this investment PulseOn will be able to finalize the productization and enter the markets during the first half of 2014. We want to disrupt the market for traditional chest belt based heart rate measurement products by offering the easiest and most comfortable solution to wider audiences. The product also offers a 2nd generation solution to the current activity based wellness monitoring devices by offering significantly more meaningful and accurate information based on continuous and accurate heart rate measurement," says Tero Mennander, Managing Director of PulseOn.

"PulseOn is a good example of a Finnish high tech company that has created a new technology based product that can truly change the markets. Coupled with a highly competent team we believe PulseOn will become a world leading heart rate solution manufacturer in the strongly growing consumer fitness and wellness markets," says Olli Pohjanvirta, Chairman of the Board and investor representative.

The main investors of this seed round are Mr. Otar Margania, a Russian banker and dean of the Economic Faculty of St. Petersburg State University and Mr. Olli Pohjanvirta.

Source:

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Breakthrough implantable cardiac pump offers hope for children awaiting heart transplants